Midas Seyda1, Markus Quante, Hirofumi Uehara, Bendix R Slegtenhorst, Abdala Elkhal, Stefan G Tullius. 1. aDivision of Transplant Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA bInstitute of Transplant Immunology, Hannover Medical School, Hannover cDepartment of Visceral, Transplantation, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany dDepartment of Urology, Osaka Medical College, Osaka, Japan eDivision of Transplant Surgery, Department of Surgery, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.
Abstract
PURPOSE OF REVIEW: With global demographic changes and an overall improved healthcare, more older end-stage renal disease (ESRD) patients receive kidney transplants. At the same time, organs from older donors are utilized more frequently. Those developments have and will continue to impact allocation, immunosuppression and efforts improving organ quality. RECENT FINDINGS: Findings mainly outside the field of transplantation have provided insights into mechanisms that drive immunosenescence and immunogenicity, thus providing a rationale for an age-adapted immunosuppression and relevant clinical trials in the elderly. With fewer rejections in the elderly, alloimmune responses appear to be characterized by a decline in effectiveness and an augmented unspecific immune response. SUMMARY: Immunosenescence displays broad and ambivalent effects in elderly transplant recipients. Those changes appear to compensate a decline in allospecific effectiveness by a shift towards an augmented unspecific immune response. Immunosuppression needs to target those age-specific changes to optimize outcomes in elderly transplant recipients.
PURPOSE OF REVIEW: With global demographic changes and an overall improved healthcare, more older end-stage renal disease (ESRD) patients receive kidney transplants. At the same time, organs from older donors are utilized more frequently. Those developments have and will continue to impact allocation, immunosuppression and efforts improving organ quality. RECENT FINDINGS: Findings mainly outside the field of transplantation have provided insights into mechanisms that drive immunosenescence and immunogenicity, thus providing a rationale for an age-adapted immunosuppression and relevant clinical trials in the elderly. With fewer rejections in the elderly, alloimmune responses appear to be characterized by a decline in effectiveness and an augmented unspecific immune response. SUMMARY: Immunosenescence displays broad and ambivalent effects in elderly transplant recipients. Those changes appear to compensate a decline in allospecific effectiveness by a shift towards an augmented unspecific immune response. Immunosuppression needs to target those age-specific changes to optimize outcomes in elderly transplant recipients.
Authors: F Borrego; M C Alonso; M D Galiani; J Carracedo; R Ramirez; B Ostos; J Peña; R Solana Journal: Exp Gerontol Date: 1999-04 Impact factor: 4.032
Authors: Stefan G Tullius; Huong Tran; Indira Guleria; Sayeed K Malek; Nicholas L Tilney; Edgar Milford Journal: Ann Surg Date: 2010-10 Impact factor: 12.969
Authors: H Myron Kauffman; Maureen A McBride; Cynthia S Cors; Allan M Roza; James J Wynn Journal: Transplantation Date: 2007-02-27 Impact factor: 4.939
Authors: Christine Neudoerfl; Bernadett J Mueller; Cornelia Blume; Kerstin Daemen; Maja Stevanovic-Meyer; Jana Keil; Frank Lehner; Hermann Haller; Christine S Falk Journal: Front Immunol Date: 2013-02-28 Impact factor: 7.561
Authors: Tanya M Monaghan; Niharika A Duggal; Elisa Rosati; Ruth Griffin; Jamie Hughes; Brandi Roach; David Y Yang; Christopher Wang; Karen Wong; Lynora Saxinger; Maja Pučić-Baković; Frano Vučković; Filip Klicek; Gordan Lauc; Paddy Tighe; Benjamin H Mullish; Jesus Miguens Blanco; Julie A K McDonald; Julian R Marchesi; Ning Xue; Tania Dottorini; Animesh Acharjee; Andre Franke; Yingrui Li; Gane Ka-Shu Wong; Christos Polytarchou; Tung On Yau; Niki Christodoulou; Maria Hatziapostolou; Minkun Wang; Lindsey A Russell; Dina H Kao Journal: Cells Date: 2021-11-19 Impact factor: 6.600
Authors: Aniruddha Srivastava; Joshua Bodnar; Fauzia Osman; Margaret R Jorgenson; Brad C Astor; Didier A Mandelbrot; Sandesh Parajuli Journal: Kidney Int Rep Date: 2020-09-19
Authors: Merve Postalcioglu; Arnaud D Kaze; Benjamin C Byun; Andrew Siedlecki; Stefan G Tullius; Edgar L Milford; Julie M Paik; Reza Abdi Journal: Transplantation Date: 2018-07 Impact factor: 4.939
Authors: Joanna M Schaenman; Maura Rossetti; Erik Lum; Basmah Abdalla; Suphamai Bunnapradist; Thu-Phuong Pham; Gabriel Danovitch; Elaine F Reed; Steve Cole Journal: Transplant Direct Date: 2019-03-04